Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

2 意见
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个